BridgeMD
New treatment option for Solid Tumor
Official title Bergonie Institut Profiling : Fighting Cancer by Matching Molecular Alterations and Drugs in Early Phase Trials
ClinicalTrials.gov ID: NCT02534649
What this study is testing
- What it's testing
- This is a biology driven, monocentric study designed to identify actionable molecular alterations in cancer patients with advanced disease. In this trial, high throughput analysis will be carried out using next generation sequencing, and immunological profiling.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age ≥ 18 years,
- Histology: solid malignant tumor or hematological malignancy,
- Deleted MSA9
- Deleted MSA9,
- Deleted MSA9,
You likely can't join if
- Deleted MSA9
- Deleted MSA9
- Deleted MSA9
- Deleted MSA9
- Deleted MSA9
- Deleted MSA9
See the full eligibility criteria
- Age ≥ 18 years,
- Histology: solid malignant tumor or hematological malignancy,
- Deleted MSA9
- Deleted MSA9,
- Deleted MSA9,
- Deleted MSA9,
- Patient with a social security in compliance with the French law relating to biomedical research (Article L.1121-11 of French Public Health Code),
- Voluntary signed and dated written informed consent prior to any study specific procedure.
- Deleted MSA9
- Deleted MSA9
- Deleted MSA9
- Deleted MSA9
- Deleted MSA9
- Deleted MSA9
- Deleted MSA9
- Deleted MSA9
- Individuals deprived of liberty or placed under guardianship
- Pregnant or breast feeding women,
- Previous enrolment in the present study.
The study team makes the final eligibility decision.
Where it's taking place
- Bayonne, France
- Bordeaux, France
- Pau, France
- Rennes, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bayonne, France; Bordeaux, France; Pau, France; Rennes, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.